Atai Beckley N.V.

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Amstelveen
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
ATAI Life Sciences N.V., By: /s/ Anne Johnson, Chief Financial Officer
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Atai Beckley N.V.

Form 4 holding 10%+ Owner

COMPASS Pathways plc

Security class
Ordinary Shares
Shares / value
6,905,774
Estimated value
$41,779,933
Report date
26 Sep 2024
Price
$6.05
Ownership
By ATAI Life Sciences AG
Form 4 holding 10%+ Owner

IntelGenx Technologies Corp.

Security class
Warrant (Right to Buy)
Shares / value
4,000,000
Estimated value
Report date
08 Mar 2024
Price
Ownership
By ATAI Life Sciences AG
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

IntelGenx Technologies Corp.

Security class
Convertible Promissory Note
Shares / value
2,970,000
Estimated value
Report date
28 Nov 2023
Price
Ownership
By ATAI Life Sciences AG
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

IntelGenx Technologies Corp.

Security class
Call Option (Right to Buy)
Shares / value
7,401
Estimated value
Report date
30 Sep 2023
Price
Ownership
By ATAI Life Sciences AG
Underlying class
Units
Underlying amount
Form 4 holding 10%+ Owner

IntelGenx Technologies Corp.

Security class
Convertible Notes
Shares / value
$10,500,000
Estimated value
Report date
19 Apr 2024
Price
Ownership
By ATAI Life Sciences AG
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Atai Beckley N.V.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .